HOME - Clinical cases - Implantology
 
 
09 July 2021

Soft tissue surgery at implant abutment connection for improving aesthetics: 6-month outcomes of a multicentre randomised controlled trial of xenogeneic dermal matrix versus autologous connective tissue graft versus no graft

Authors: Niccolò Baldi, Jacopo Buti, Magda Mensi, Fortunato Alfonsi, Chiara Cinquini, Paolo Tonelli, Antonio Barone


Objectives. The aim of this multicentre randomised controlled trial was to evaluate the efficacy of a xenogeneic dermal matrix in widening keratinised peri-implant tissues during second-stage surgery, and to compare it to both autologous connective tissue graft and a control group with no augmentation. 

Material and methods. Patients requiring an increase in keratinised gingiva width were enrolled by four university/dental practices and randomised into three different groups for grafting procedures at the implant uncovering stage: either xenogeneic dermal matrix (Group X), autologous connective tissue graft (A) or no graft (control, Group C). The primary outcomes were width of keratinised tissue and facial soft tissue levels, evaluated at three different time points (T0, implant uncovering stage; T1 and T2, six weeks and six months after surgery, respectively). Secondary outcomes were: implant failure, complications, marginal bone loss, papilla index, facial soft tissue level, pink aesthetic score, and aesthetic assessment by patients. 

Results. Thirty-six patients, with one implant per patient, were enrolled at two centres (18 at each centre): 12 for control, 12 for xenogeneic dermal matrix and 12 for autologous tissue graft. Three patients dropped out and two patients from the autologous group had implant failures. No complications were recorded. After six months, the width of keratinised tissue increased by 0.16 ± 1.01 (P = 0.79), 1.05 ± 0.76 (P = 0.01) and 0.80 ± 1.73 mm (P = 0.28), and facial soft tissue level was -0.95 ± 0.85 (P = 0.04), 0.32 ± 0.57 (P = 0.15) and 0.35 ± 0.79 mm (P = 0.30) respectively in Groups C, X and A groups. Between-group analysis showed that, with respect to control, only facial soft tissue level (1.31 mm, P = 0.01) and width of keratinised mucosa (2.43 mm, P = 0.01) outcomes in the autologous graft group were statistically significant at T2. Mean marginal bone loss between T0-T2 was -0.4 ± 0.4mm, with no differences between groups. Pink aesthetic score showed no significant differences between groups, being 0.89 for A-C (P = 0.41), 0.88 for A–X (P = 0.63) and 0.72 for X-C (P = 0.88). 

Patient’s aesthetic satisfaction (Visual Analogue Scale) was 92.2 ± 8.4, 93.8 ± 7.7, 97.2 ± 3.0, for Groups C, X and A, respectively. Between the two dental centres, only facial soft tissue level at T0–T2 was significantly different, by 0.67 ± 0.62 mm (P = 0.03).

Conclusions. After six months, autologous connective tissue graft yielded a significant gain in facial soft tissue levels and width of keratinised mucosa, as compared to the control group (no graft). 


Read more

Florida based National Dentex Labs, maker of prosthetics and restorative dentistry products, has acquired Fager Dental Lab of Pennsylvania. NDX has acquired labs of late in an effort to expand its...


Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for...


Authors: Giulia Pradal, Daniela Sorrentino, Niccolò Lombardi, Alberto Pispero, Laura Moneghini

A 76-year-old male patient was sent to the oral medicine service of the San Paolo Hospital in Milan for the presence of a radiolucent lesion at the level of the left mandibular corner, found through...


vTail, maker of a platform for healthcare communication, has brought its technology to the US dental market. The app connects healthcare professionals with medical products firms and provides...


Henry Schein announced its presence at the 2021 Greater New York Dental Meeting, featuring a rich lineup of product demonstrations and educational offerings designed to help oral health professionals enhance practice efficiency.

Visitors to the GNYDM can explore the Company’s comprehensive portfolio of products and solutions that help optimize every step of the practice workflow, including digital equipment, technology...


 
 
 
 
 
 

Most popular

 
 

Events

 
 

Copyright © 2021 - All Rights Reserved
ISSN 2767-1178

Top